ANI Biome

Ani Biome is an AI-powered longevity and biotechnology company focused on decoding the brain-immune-gut (BIG) axis to address systemic inflammation and slow biological aging. The company leverages its proprietary machine learning platform, ANI.AI, alongside deep multi-omics and longitudinal digital phenotyping (such as tongue and skin scans) to analyze individual biological states. Based on these insights, Ani Biome designs and produces 'AgeBiotics'—personalized, highly bioavailable fermentation-derived metabolites and small molecule blends that modulate the gut microbiome to act as an internal bioreactor. By promoting the production of short-chain fatty acids (SCFAs), these tailored interventions aim to reduce low-grade chronic inflammation, enhance systemic resilience, and extend human healthspan.